Journal Menu
► ▼ Journal MenuJournal Browser
► ▼ Journal Browser-
arrow_forward_ios
Forthcoming issue
arrow_forward_ios Current issue - Volumes not published by MDPI
- Vol. 42 (2021)
- Vol. 41 (2021)
- Vol. 40 (2021)
- Vol. 39 (2020)
- Vol. 38 (2020)
- Vol. 37 (2020)
- Vol. 36 (2020)
- Vol. 35 (2020)
- Vol. 34 (2019)
- Vol. 33 (2019)
- Vol. 32 (2019)
- Vol. 31 (2019)
- Vol. 30 (2019)
- Vol. 29 (2018)
- Vol. 28 (2018)
- Vol. 27 (2018)
- Vol. 26 (2018)
- Vol. 25 (2018)
- Vol. 24 (2017)
- Vol. 23 (2017)
- Vol. 22 (2017)
- Vol. 21 (2017)
- Vol. 20 (2016)
- Vol. 19 (2016)
- Vol. 18 (2016)
- Vol. 17 (2015)
- Vol. 16 (2014)
- Vol. 15 (2013)
- Vol. 14 (2012)
- Vol. 13 (2011)
- Vol. 12 (2010)
- Vol. 11 (2009)
- Vol. 10 (2008)
- Vol. 9 (2007)
- Vol. 8 (2006)
- Vol. 7 (2005)
- Vol. 6 (2004)
- Vol. 5 (2003)
- Vol. 4 (2002)
- Vol. 3 (2001)
- Vol. 2 (2000)
- Vol. 1 (1999)
Need Help?
Awards
CIMB 2024 Outstanding Reviewer Award
Dear Colleagues,
On behalf of the journal’s Editor-in-Chief, Prof. Dr. Madhav Bhatia, we wish to acknowledge our reviewers, who so generously offer their time to review the papers submitted to CIMB, by presenting an award to those who have demonstrated their dedication, professionalism, and timeliness in reviewing manuscripts for CIMB.
What are the pre-requisites to be eligible for this award?
– All of the reviewers for CIMB in 2024 will be automatically included.
Selection criteria:
– Number of review reports;
– The quality and timeliness of review reports.
What will the winners receive?
There will be two winners this year, and each will receive the following:
– CHF 500;
– An opportunity to publish a paper free of charge in 2024;
– A certificate.
When will the winners be announced?
– The winners will be announced in March 2025 on the journal’s website.
How can I make myself eligible?
– If you have not yet reviewed papers for CIMB, but would like to do so, you can register as a reviewer at the following link:
https://susy.mdpi.com/volunteer/profile/edit.
Kind regards,
CIMB Editorial Office
CIMB 2023 Best Paper Award
Dear Colleagues,
We are pleased to announce the “CIMB 2023 Best Paper Award” for research and review articles published in CIMB from 1 January 2023 to 31 December 2023. One review and one research article will receive an award each. The papers will be selected after a thorough evaluation by the journal Award Committee led by the Editor-in-Chief, Prof. Dr. Madhav Bhatia.
Eligibility for the Award:
– Papers published in CIMB from 1 January 2023 to 31 December 2023;
– Open to all career levels;
– Both regular and Special Issue submissions will be considered.
Selection Criteria:
The papers will be selected by the journal Award Committee according to the following criteria:
– Scientific merit and broad impact;
– Originality of the research objectives and/or the ideas presented;
– Creativity of the study design or uniqueness of the approaches and concepts;
– Clarity of presentation;
– Citations and downloads.
The Prize:
– One review award: CHF 500 and a chance to publish a paper free of charge in CIMB in 2025;
– One research article award: CHF 500 and a chance to publish a paper free of charge in CIMB in 2025;
– Each winner will also receive a certificate.
The winners will be announced on the journal website in June 2025.
Kind regards,
CIMB Editorial Office
Closed Awards
CIMB 2023 Outstanding Reviewer Award
Dear Colleagues,
We are pleased to announce the winners of the CIMB 2023 Outstanding Reviewer Award. The CIMB Editorial Board and Editorial Team would like to gratefully acknowledge the time and energy dedicated by reviewers in checking the manuscripts submitted to CIMB. It is due to their efforts that the high quality of the journal and quick turnaround are maintained.
Dr. Georgios Pampalakis
School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece
Research interests: proteases; kallikreins; prostate-specific antigen; skin (patho)physiology; organophosphates; chemobrionics
Dr. Katsura Takano
Laboratory of Integrative Physiology in Veterinary Sciences, Osaka Prefecture University, Osaka, Japan
Research interests: neurodegenerative diseases; astrocyte; microglia; neuropharmacology; neurochemistry; spinal cord injury; pain
The Prize for Each Winner:
– CHF 500;
– The opportunity to publish a paper free of charge in CIMB in 2024;
– A certificate.
Kind regards,
CIMB Editorial Office
CIMB 2022 Best Paper Award
Dear Colleagues,
We are pleased to announce the winners of the CIMB 2022 Best Paper Award. All papers published in 2022 in CIMB were considered for the award. After a thorough evaluation of the originality and significance of the papers, citations, and downloads, two winners were selected.
One Review:
Circulating Exosomal miR-1290 for Diagnosis of Epithelial Ovarian Cancer
By Hyeji Jeon, Su Min Seo, Tae Wan Kim, Jaesung Ryu, Hyejeong Kong, Hyeong Jang, Yong Soo Jang, Kwang Seock Kim, Jae Hoon Kim, Seongho Ryu and Seob Jeon
Curr. Issues Mol. Biol. 2022, 44(1), 288-300; doi:10.3390/cimb44010021
One Article:
Lipid Nanoparticles: A Novel Gene Delivery Technique for Clinical Application
By Ryuichi Mashima and Shuji Takada
Curr. Issues Mol. Biol. 2022, 44(10), 5013-5027; doi:10.3390/cimb44100341
Each winner will receive CHF 500 and a chance to publish a paper in CIMB in 2024.
Please join us in congratulating the winners of the CIMB 2022 Best Paper Award. We would also like to take this opportunity to thank all of our authors for their continued support of CIMB.
Kind regards,
CIMB Editorial Office
CIMB 2022 Outstanding Reviewer Award
Dear Colleagues,
We are pleased to announce the winners of the CIMB 2022 Outstanding Reviewer Award. The CIMB Editorial Board and Editorial Team would like to gratefully acknowledge the time and energy dedicated by reviewers in checking the manuscripts submitted to CIMB. It is due to their efforts that the high quality of the journal and quick turnaround are maintained.
Dr. Pasquale Pisapia
Department of Public Health, University of Naples Federico II, Naples, Italy
Research Interests: non-small cell lung cancer; next generation sequencing; colon cancer; liquid biopsy; immunotherapy
Dr. Daniel Abegg
Department of Chemistry, The Scripps Research Institute, Jupiter, FL, USA
Research Interests: biochemistry; chemical biology; mass spectrometry; chemoproteomics; proteomics; cellular delivery
The Prize for Each Winner:
– CHF 500;
– An opportunity to publish a paper free of charge in CIMB in 2023 after peer review;
– A certificate.
Kind regards,
CIMB Editorial Office
